Home/Filings/4/0000899243-20-019850
4//SEC Filing

Third Rock Ventures III, L.P. 4

Accession 0000899243-20-019850

CIK 0001812364other

Filed

Jul 20, 8:00 PM ET

Accepted

Jul 21, 7:23 PM ET

Size

34.9 KB

Accession

0000899243-20-019850

Insider Transaction Report

Form 4
Period: 2020-07-20
Transactions
  • Conversion

    Series B Convertible Preferred Stock

    2020-07-2061,8810 total
    Common Stock (17,427 underlying)
  • Conversion

    Common Stock

    2020-07-20+9,970,4549,970,454 total
  • Conversion

    Common Stock

    2020-07-20+17,4279,987,881 total
  • Conversion

    Series A Convertible Preferred Stock

    2020-07-2035,404,2860 total
    Common Stock (9,970,454 underlying)
  • Conversion

    Series B Convertible Preferred Stock

    2020-07-2061,8810 total(indirect: See Footnotes)
    Common Stock (17,427 underlying)
  • Conversion

    Common Stock

    2020-07-20+17,4272,811,197 total(indirect: See Footnotes)
  • Conversion

    Series A Convertible Preferred Stock

    2020-07-209,920,4550 total(indirect: See Footnotes)
    Common Stock (2,793,770 underlying)
  • Conversion

    Common Stock

    2020-07-20+2,793,7702,793,770 total(indirect: See Footnotes)
Transactions
  • Conversion

    Series A Convertible Preferred Stock

    2020-07-209,920,4550 total(indirect: See Footnotes)
    Common Stock (2,793,770 underlying)
  • Conversion

    Series A Convertible Preferred Stock

    2020-07-2035,404,2860 total
    Common Stock (9,970,454 underlying)
  • Conversion

    Common Stock

    2020-07-20+9,970,4549,970,454 total
  • Conversion

    Common Stock

    2020-07-20+17,4272,811,197 total(indirect: See Footnotes)
  • Conversion

    Series B Convertible Preferred Stock

    2020-07-2061,8810 total
    Common Stock (17,427 underlying)
  • Conversion

    Common Stock

    2020-07-20+2,793,7702,793,770 total(indirect: See Footnotes)
  • Conversion

    Common Stock

    2020-07-20+17,4279,987,881 total
  • Conversion

    Series B Convertible Preferred Stock

    2020-07-2061,8810 total(indirect: See Footnotes)
    Common Stock (17,427 underlying)
Transactions
  • Conversion

    Common Stock

    2020-07-20+9,970,4549,970,454 total
  • Conversion

    Common Stock

    2020-07-20+17,4279,987,881 total
  • Conversion

    Common Stock

    2020-07-20+17,4272,811,197 total(indirect: See Footnotes)
  • Conversion

    Series A Convertible Preferred Stock

    2020-07-2035,404,2860 total
    Common Stock (9,970,454 underlying)
  • Conversion

    Series B Convertible Preferred Stock

    2020-07-2061,8810 total
    Common Stock (17,427 underlying)
  • Conversion

    Common Stock

    2020-07-20+2,793,7702,793,770 total(indirect: See Footnotes)
  • Conversion

    Series A Convertible Preferred Stock

    2020-07-209,920,4550 total(indirect: See Footnotes)
    Common Stock (2,793,770 underlying)
  • Conversion

    Series B Convertible Preferred Stock

    2020-07-2061,8810 total(indirect: See Footnotes)
    Common Stock (17,427 underlying)
LEVIN MARK J
10% Owner
Transactions
  • Conversion

    Common Stock

    2020-07-20+9,970,4549,970,454 total
  • Conversion

    Common Stock

    2020-07-20+2,793,7702,793,770 total(indirect: See Footnotes)
  • Conversion

    Common Stock

    2020-07-20+17,4279,987,881 total
  • Conversion

    Series A Convertible Preferred Stock

    2020-07-2035,404,2860 total
    Common Stock (9,970,454 underlying)
  • Conversion

    Common Stock

    2020-07-20+17,4272,811,197 total(indirect: See Footnotes)
  • Conversion

    Series B Convertible Preferred Stock

    2020-07-2061,8810 total(indirect: See Footnotes)
    Common Stock (17,427 underlying)
  • Conversion

    Series A Convertible Preferred Stock

    2020-07-209,920,4550 total(indirect: See Footnotes)
    Common Stock (2,793,770 underlying)
  • Conversion

    Series B Convertible Preferred Stock

    2020-07-2061,8810 total
    Common Stock (17,427 underlying)
STARR KEVIN P
10% Owner
Transactions
  • Conversion

    Series A Convertible Preferred Stock

    2020-07-209,920,4550 total(indirect: See Footnotes)
    Common Stock (2,793,770 underlying)
  • Conversion

    Common Stock

    2020-07-20+2,793,7702,793,770 total(indirect: See Footnotes)
  • Conversion

    Common Stock

    2020-07-20+17,4272,811,197 total(indirect: See Footnotes)
  • Conversion

    Common Stock

    2020-07-20+17,4279,987,881 total
  • Conversion

    Series A Convertible Preferred Stock

    2020-07-2035,404,2860 total
    Common Stock (9,970,454 underlying)
  • Conversion

    Series B Convertible Preferred Stock

    2020-07-2061,8810 total(indirect: See Footnotes)
    Common Stock (17,427 underlying)
  • Conversion

    Common Stock

    2020-07-20+9,970,4549,970,454 total
  • Conversion

    Series B Convertible Preferred Stock

    2020-07-2061,8810 total
    Common Stock (17,427 underlying)
Transactions
  • Conversion

    Series A Convertible Preferred Stock

    2020-07-209,920,4550 total(indirect: See Footnotes)
    Common Stock (2,793,770 underlying)
  • Conversion

    Common Stock

    2020-07-20+9,970,4549,970,454 total
  • Conversion

    Common Stock

    2020-07-20+17,4272,811,197 total(indirect: See Footnotes)
  • Conversion

    Series A Convertible Preferred Stock

    2020-07-2035,404,2860 total
    Common Stock (9,970,454 underlying)
  • Conversion

    Common Stock

    2020-07-20+2,793,7702,793,770 total(indirect: See Footnotes)
  • Conversion

    Common Stock

    2020-07-20+17,4279,987,881 total
  • Conversion

    Series B Convertible Preferred Stock

    2020-07-2061,8810 total
    Common Stock (17,427 underlying)
  • Conversion

    Series B Convertible Preferred Stock

    2020-07-2061,8810 total(indirect: See Footnotes)
    Common Stock (17,427 underlying)
Transactions
  • Conversion

    Common Stock

    2020-07-20+2,793,7702,793,770 total(indirect: See Footnotes)
  • Conversion

    Common Stock

    2020-07-20+17,4272,811,197 total(indirect: See Footnotes)
  • Conversion

    Series A Convertible Preferred Stock

    2020-07-209,920,4550 total(indirect: See Footnotes)
    Common Stock (2,793,770 underlying)
  • Conversion

    Series B Convertible Preferred Stock

    2020-07-2061,8810 total(indirect: See Footnotes)
    Common Stock (17,427 underlying)
  • Conversion

    Common Stock

    2020-07-20+9,970,4549,970,454 total
  • Conversion

    Common Stock

    2020-07-20+17,4279,987,881 total
  • Conversion

    Series A Convertible Preferred Stock

    2020-07-2035,404,2860 total
    Common Stock (9,970,454 underlying)
  • Conversion

    Series B Convertible Preferred Stock

    2020-07-2061,8810 total
    Common Stock (17,427 underlying)
Transactions
  • Conversion

    Common Stock

    2020-07-20+9,970,4549,970,454 total
  • Conversion

    Common Stock

    2020-07-20+17,4279,987,881 total
  • Conversion

    Series B Convertible Preferred Stock

    2020-07-2061,8810 total
    Common Stock (17,427 underlying)
  • Conversion

    Series B Convertible Preferred Stock

    2020-07-2061,8810 total(indirect: See Footnotes)
    Common Stock (17,427 underlying)
  • Conversion

    Common Stock

    2020-07-20+2,793,7702,793,770 total(indirect: See Footnotes)
  • Conversion

    Common Stock

    2020-07-20+17,4272,811,197 total(indirect: See Footnotes)
  • Conversion

    Series A Convertible Preferred Stock

    2020-07-2035,404,2860 total
    Common Stock (9,970,454 underlying)
  • Conversion

    Series A Convertible Preferred Stock

    2020-07-209,920,4550 total(indirect: See Footnotes)
    Common Stock (2,793,770 underlying)
Transactions
  • Conversion

    Common Stock

    2020-07-20+2,793,7702,793,770 total(indirect: See Footnotes)
  • Conversion

    Series A Convertible Preferred Stock

    2020-07-2035,404,2860 total
    Common Stock (9,970,454 underlying)
  • Conversion

    Series B Convertible Preferred Stock

    2020-07-2061,8810 total
    Common Stock (17,427 underlying)
  • Conversion

    Series B Convertible Preferred Stock

    2020-07-2061,8810 total(indirect: See Footnotes)
    Common Stock (17,427 underlying)
  • Conversion

    Series A Convertible Preferred Stock

    2020-07-209,920,4550 total(indirect: See Footnotes)
    Common Stock (2,793,770 underlying)
  • Conversion

    Common Stock

    2020-07-20+9,970,4549,970,454 total
  • Conversion

    Common Stock

    2020-07-20+17,4272,811,197 total(indirect: See Footnotes)
  • Conversion

    Common Stock

    2020-07-20+17,4279,987,881 total
Footnotes (7)
  • [F1]These shares are directly held by Third Rock Ventures III, L.P. ("TRV III").
  • [F2]The general partner of TRV III is Third Rock Ventures GP III, L.P. ("TRV GP III"). The general partner of TRV GP III is TRV GP III, LLC ("TRV GP III LLC"). The individual managers of TRV GP III LLC are Mark Levin ("Levin"), Kevin Starr ("Starr") and Dr. Robert Tepper ("Tepper"). Each of the reporting persons, except for TRV III, disclaims beneficial ownership of these shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares.
  • [F3]Each share of Series A Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") on a 1-for-3.55092 basis upon the closing of the Issuer's initial public offering on July 20, 2020 and had no expiration date.
  • [F4]These shares are directly held by Third Rock Ventures IV, L.P. ("TRV IV").
  • [F5]The general partner of TRV IV is Third Rock Ventures GP IV, L.P. ("TRV GP IV"). The general partner of TRV GP IV is TRV GP IV, LLC ("TRV GP IV LLC"). Each of the reporting persons, except for TRV IV, disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares.
  • [F6]Each share of Series B Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") on a 1-for-3.55092 basis upon the closing of the Issuer's initial public offering on July 20, 2020 and had no expiration date.
  • [F7]Each of the reporting persons disclaims the existence of a Section 13(d) "group" as between the TRV III related parties and the TRV IV related parties and this report shall not be deemed an admission that any of such parties is or may be part of such a group with any of the other parties.

Issuer

Relay Therapeutics, Inc.

CIK 0001812364

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001569705

Filing Metadata

Form type
4
Filed
Jul 20, 8:00 PM ET
Accepted
Jul 21, 7:23 PM ET
Size
34.9 KB